Search research articles
Contact Us
Filters
Showing results (121-130 of 150) with videos related to
Page
of 15
Sort By:
Haematologica
|
June 21, 2011
Charlson comorbidity index and adult comorbidity evaluation-27 scores might predict treatment compliance and development of pleural effusions in elderly patients with chronic myeloid leukemia treated with second-line dasatinib
Massimo Breccia, Roberto Latagliata, Fabio Stagno, et al.
Insights Into Imaging
|
June 4, 2021
Diagnostic methods and therapeutic options of uveal melanoma with emphasis on MR imaging-Part II: treatment indications and complications
Pietro Valerio Foti, Mario Travali, Renato Farina, et al.
Cells
|
November 27, 2021
Novel Mechanisms of Tumor Promotion by the Insulin Receptor Isoform A in Triple-Negative Breast Cancer Cells
Veronica Vella, Marika Giuliano, Alessandro La Ferlita, et al.
Cancers
|
January 11, 2022
Histopathologic and MR Imaging Appearance of Spontaneous and Radiation-Induced Necrosis in Uveal Melanomas: Initial Results
Pietro Valerio Foti, Corrado Inì, Giuseppe Broggi, et al.
Exploration of Targeted Anti-Tumor Therapy
|
July 28, 2025
Correlation between histopathological features and recurrence score according to menopausal status in HR+/HER2- breast cancer patients: a retrospective study
Federica Martorana, Sabrina Nucera, Gianmarco Motta, et al.
Plos One
|
June 26, 2015
Flow Cytometric Immunobead Assay for Detection of BCR-ABL1 Fusion Proteins in Chronic Myleoid Leukemia: Comparison with FISH and PCR Techniques
Anna Grazia Recchia, Nadia Caruso, Sabrina Bossio, et al.
Frontiers in Oncology
|
August 29, 2019
<i>BCR-ABL1</i> Doubling-Times and Halving-Times May Predict CML Response to Tyrosine Kinase Inhibitors
Maria Stella Pennisi, Stefania Stella, Silvia Rita Vitale, et al.
JNCI Cancer Spectrum
|
August 12, 2025
Comparative efficacy between real-world and randomized studies of palbociclib+endocrine therapy in HR-positive/HER2-negative metastatic breast cancer: systematic review and meta-analysis
Francesco Schettini, Sabrina Nucera, Giuseppe Di Grazia, et al.
Biomolecules
|
January 25, 2025
An Optimized NGS Workflow Defines Genetically Based Prognostic Categories for Patients with Uveal Melanoma
Michele Massimino, Elena Tirrò, Stefania Stella, et al.
BMC Cancer
|
March 25, 2021
Detection of tumor-derived extracellular vesicles in plasma from patients with solid cancer
Silvia R Vitale, Jean A Helmijr, Marjolein Gerritsen, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 150) with videos related to
Sort By:
Page
of 15
Haematologica
|
June 21, 2011
Charlson comorbidity index and adult comorbidity evaluation-27 scores might predict treatment compliance and development of pleural effusions in elderly patients with chronic myeloid leukemia treated with second-line dasatinib
Massimo Breccia, Roberto Latagliata, Fabio Stagno, et al.
Insights Into Imaging
|
June 4, 2021
Diagnostic methods and therapeutic options of uveal melanoma with emphasis on MR imaging-Part II: treatment indications and complications
Pietro Valerio Foti, Mario Travali, Renato Farina, et al.
Cells
|
November 27, 2021
Novel Mechanisms of Tumor Promotion by the Insulin Receptor Isoform A in Triple-Negative Breast Cancer Cells
Veronica Vella, Marika Giuliano, Alessandro La Ferlita, et al.
Cancers
|
January 11, 2022
Histopathologic and MR Imaging Appearance of Spontaneous and Radiation-Induced Necrosis in Uveal Melanomas: Initial Results
Pietro Valerio Foti, Corrado Inì, Giuseppe Broggi, et al.
Exploration of Targeted Anti-Tumor Therapy
|
July 28, 2025
Correlation between histopathological features and recurrence score according to menopausal status in HR+/HER2- breast cancer patients: a retrospective study
Federica Martorana, Sabrina Nucera, Gianmarco Motta, et al.
Plos One
|
June 26, 2015
Flow Cytometric Immunobead Assay for Detection of BCR-ABL1 Fusion Proteins in Chronic Myleoid Leukemia: Comparison with FISH and PCR Techniques
Anna Grazia Recchia, Nadia Caruso, Sabrina Bossio, et al.
Frontiers in Oncology
|
August 29, 2019
<i>BCR-ABL1</i> Doubling-Times and Halving-Times May Predict CML Response to Tyrosine Kinase Inhibitors
Maria Stella Pennisi, Stefania Stella, Silvia Rita Vitale, et al.
JNCI Cancer Spectrum
|
August 12, 2025
Comparative efficacy between real-world and randomized studies of palbociclib+endocrine therapy in HR-positive/HER2-negative metastatic breast cancer: systematic review and meta-analysis
Francesco Schettini, Sabrina Nucera, Giuseppe Di Grazia, et al.
Biomolecules
|
January 25, 2025
An Optimized NGS Workflow Defines Genetically Based Prognostic Categories for Patients with Uveal Melanoma
Michele Massimino, Elena Tirrò, Stefania Stella, et al.
BMC Cancer
|
March 25, 2021
Detection of tumor-derived extracellular vesicles in plasma from patients with solid cancer
Silvia R Vitale, Jean A Helmijr, Marjolein Gerritsen, et al.
Page
of 15